Diagnostics chain Metropolis Healthcare, which is launching a Rs 1,200-crore initial public offering (IPO) this week, Monday said it is looking at acquisitions as an integral part of its growth strategy.
Besides acquisitions, the company is also focusing on robust organic growth and new avenues for expansion going forward.
The IPO opens on April 3 and closes on April 5, 2019. The price band has been fixed at Rs 877-880 per equity share.
When asked about the reasons for the launch of the IPO, Metropolis Healthcare Chairman Sushil Shah told PTI: "The most important reason was that in case going forward if we have a very big acquisition opportunity we will have ease of borrowing from banks ... It is easier to do this when one is a public listed company."